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SKIN SENSITIZATION BY MERCAPTANS OF LOW MOLECULAR
WEIGHT*
J. G. VOSS, Pff.D;
The principal objectives of this communication
are to demonstrate (a) the activity of some simple
mercaptans as an interesting class of water-
soluble allergens, (b) the utility of the guinea pig
in predicting the allergenicity of new compounds
for man, and (c) an improved patch test method
which more clearly distinguishes between primary
irritation and sensitization in human subjects.
In the literature relating to contact hypersensi-
tivity to simple compounds, there are few refer-
ences to sensitization to mercaptans. Human
sensitization has been reported with thioglycerol
(1, 2), 2,3-dimercaptopropanol (BAL) (3), and
3 ,3-dimethylcysteine (4). Thioglycerol has also
been found to induce sensitization in the guinea
pig, after topical application (5) or intradermal
injection (6). In addition, Brunner and Smijanic
(7) reported sensitization to two unidentified
mercaptans after repeated patch tests.
Recent work in our laboratories has been
devoted to a search for a mercaptan other than
thioglycolate which might also be useful as the
active ingredient in hair-waving lotions. It was
soon found that sensitization by a number of
mercaptans other than thioglycolate could be
demonstrated. Attention was therefore given to
the refinement of methods for detection of aller-
genicity of new mercaptans, with the dual aim of
(a) improving animal methods in order to circum-
vent the need for using human subjects in
screening tests, and (b) assuring that a mercaptan
with appreciable sensitizing potential would not
be introduced into a widely distributed product.
For determination of sensitization in animals,
the guinea pig is obviously the species of choice.
The method of Draize, et al. (8) has been widely
used, and served as the basis for our animal
studies. Experience of the last several years has
shown that the "prophetic patch test" of
Schwartz and Peck (9), in which one or two
applications of patches are relied upon to induce
sensitization in man, is not as effective in the
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detection of allergens as are methods involving a
greater number of sensitizing applications (7, 10,
11, 12). Therefore, our tests on human subjects
were carried out with a "repeated insult" patch
test method along the lines suggested by Draize
(13). This procedure was modified so as to permit
a better differentiation between sensitization and
primary irritation or "skin fatigue" (10, 13).
MATERIALS AND METHODS
Maeriale
Those compounds which were not commercially
available were synthesized in our laboratories.
Aqueous solutions of test compounds were
adjusted topH 9.0-9.3 with ammonia, and stored
under nitrogen in the refrigerator in order to
retard oxidation. Each time the flask was opened
for removal of sample, the air space was flushed
out with nitrogen before replacement of the
rubber stopper.
Guinea Pig Seneitization
Efforts to sensitize guinea pigs were carried out
by repeated intradermal injections (8). Animals
of the Connaught or Hartley strains, weighing
about 300 gm., were used. The hair was removed
from one side of the animal with electric clippers.
Three injections were made on that side each
week, until a total of ten injections had been
given. The first dose was 0.05 ml., and succeeding
doses were all 0.10 ml. of solution. Concentration
of the test compound was as high as could be
used without causing excessive irritation or
necrosis at the sites of injection.
Between ten and fourteen days after the last
injection, control animals were injected with 0.05
mL of one or more concentrations of the mer-
captan, in order to determine the highest con-
centration which could be used and still produce
minimal irritation (no necrosis, and an erythema-
tous area no more than 5 mm. in diameter). The
test animals were then challenged with that
concentration by injection of 0.05 ml. on the
previously untreated side, after clipping. An
additional four or five untreated controls were
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injected in the same manner. On the following
day, the remaining hair stubble in the treated
areas was removed with yellow barium suffide,
as suggested by Pitesky and Last (14). This pro-
cedure gave a clean skin surface free of hair, with
no evidence of irritation due to depilation. An
hour later, reactions were graded for degree and
extent of erythema, for degree of edema, and for
necrosis. Comparison of reactions on test and
control animals generally permitted an unequi-
vocal decision as to whether sensitization had
occurred. With proper choice of concentration,
control reactions generally showed erythematous
areas less than 5 mm. in diameter, with minimal
edema and no necrosis. Sensitization was usually
revealed by the presence of vividly erythematous
areas 8—12 mm. in diameter, with moderate
edema and sometimes marked necrosis at the
site of injection.
In some cases, a more concentrated but still
non-irritating solution of the test mercaptan was
applied topically to the previously untreated side
at challenge, near the site of the challenge injec-
tion. The mercaptan was dissolved in a mixture
of 45% water, 45% methyl cellosolve, and 10%
polyoxyethylene sorbitan monooleate (Tween
80®). This vehicle was suggested by Eisen (15) as
particularly suitable for demonstrating sensitiza-
tion by topical application. Reactions to topical
challenge generally paralleled reactions to intra-
dermal injection; however, there were some cases
in which sensitization was revealed by edema-
tous, erythematous reaction to topical applica-
tion but not to injection. The vehicle shown
above was much more useful as a solvent for
eliciting reactions in sensitized animals than was
water alone.
Human Sen.stizaiion
Early attempts to induce sensitization to
mercaptans in man were carried out with the
"prophetic patch test" (9). However, it was soon
found that the "repeated insult patch test" (13)
was much more effective for this purpose. Pilot
groups of ten or twelve subjects were used; if
negative results were obtained in these tests,
larger groups of about sixty subjects were then
used.1
Concentration of the mercaptan was generally
equivalent to 1.25% thioglycolate, or one-fourth
of the concentration of thioglycolate commonly
used in a waving lotion. At higher concentrations,
primary irritation was too frequently encoun-
tered. In the later work, only male subjects were
used; in an early test, it was found that a few
female subjects sensitized to thioglycolamide
became cross-sensitized to thioglycolate. Because
of this possibility of cross-sensitization, only one
mercaptan was applied to each subject.
Patches consisted of swatches of cotton flannel,
% in. by 7. in., moistened with 0.5 ml. of test
solution and applied under Duke Elastoplast
Coverlets No. 3ØQ2 The patches were applied to
the same sites on the upper arm on Monday,
Wednesday, and Friday, for three consecutive
weeks, and were removed twenty-four hours
after application. Reactions were read at the
time of the next application, and graded on a
scale of 0—6:
0—no reaction
1—slight erythema
2—marked erythema
3—erythema and edema, or erythema and
papules
4—erythema, edema and papules
5.—vesicular eruption
6—strong reaction (grade 3—5) extending
beyond site of patch
With an active allergen, it was frequently
observed that a reaction of grade 3 or higher
would appear suddenly at about the seventh
application. If this reaction was obtained after
another application, this time on a fresh site,
that subject was presumed to have become
sensitized to the mercaptan. No further patches
were applied until the time of challenge.
Approximately ten days after the last applica-
tion, the subjects were challenged by application
of patches to the original site and to a fresh site
immediately adjacent to the original. The patches
were removed after twenty-four hours, and
reactions were read after forty-eight and ninety-
six hours. The use of a patch on a fresh site had
been found very helpful in distinguishing sensiti-
zation from "skin fatigue" (10, 13); fatiguing of
skin (in the sense of a non-specific hyperirrit-
ability) was found in other patch tests with
primary irritants to be rather sharply limited to
the area of the patch, whereas sensitization
involves a rapidly spreading hypersensitivity of
1 Patch tests were carried out by Hill Top Duke Laboratories, Inc., Stamford, Connecti-
Research Institute, Inc., Miamivifle, Ohio. cut.
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TABLE I
Sensitization of Man and Guinea Pig by Mercaptans
Man Guinea Pig
Mercaptan c,.i
Sensitizing No. of Sensi- Sensitizing No. of Sensi-
concentration subjects tized concentration animals tized
Molar % % Molar %
Thioglycolate (mercaptoacetate) de-
rivatives
Mercaptoacetic acid (Thioglycolic
acid) 1.25 0.14 20 0 2.5 0.28 2.5 10 0
3-Mercaptopropionic acid 1.44 0.14 49 0 2.5 0.24 2.5 10 10?
2-Mercaptopropionic acid 1.44 0.14 41 10
2-Methoxyethylmercaptoacetate 2.04 0.14 43 30 2.5 0.17 2.5 10 40
Thioglycolamide (mercaptoacetamide)
derivatives
Mercaptoacetamide (Thioglycola-
mide) 1.25 0.14 38 90 2.5 0.28 1.0 or 20 85
2.5
N-(2-hydroxyethyl) - mercaptoacet-
amide 0.68 0.11 0.14 5 40
N-methyl mercaptoacetamide 1.42 0.14 9 44 2.5 0.25 2.5 10 0
N,N-dimethylmercaptoacetamide.... 1.62 0.14 11 45 2.5 0.22 2.5 10 20
N-(2,3-dihydroxypropyl) - mercapto-
acetamide 2.5 0.16 2.5 5 40
N-(2-methoxyethyl) - mercaptoacet-
amide 2.5 0.17 2.5 5 40
N-(polyethyleneglycol) - mercaptoac-
etamide 2.5 0.12 2.5 5 100
Mercaptoacethydrazide 1.51 0.14 28 68 2.5 0.24 2.5 9 89
N-(mercaptoacetyl)-glycine 1.85 0.14 10 30 3.2 0.22 1.6 5 0
N-(mercaptoacetyl)-urea 1.8 0.14 11 45 3.7 0.28 0.7 5 0
2-Mercaptopropionamide 2.9 0.28 32 97 1.0 0.095 1.0 9 22
N-(mercaptoacetyl)-anthranilic acid.. 2.5 0.21 2.5 8 50
N-(2-hydroxyethyl) - 3-mercaptopro-
pionamide 3.3 0.22 0.82 5 20
N, N-bis-(2-hydroxyethyl) - mercap-
toacetamide 2.5 0.14 1.0 4 75
N-(1, 1-dimethylolethyl) - mercapto-
acetamide 2.5 0.14 10 20—30 2.5 0.14 1.0 5 0
3-Mercaptopropionamide 1.4 0.14 10 30 2.3 0.21 2.3 5 0
N-Mercaptoacetyl glycinamide 3.22 0.22 1.0 4 75
N-trimethylolmethyl - mercaptoacet-
amide 2.7 0.14 60 3 4.3 0.22 1.2 5 0
N-Mercaptoethyl derivatives
2-Mercaptoethylamine 2.5 0.32 0.25 5 0
N-(2-mercaptoethyl)-pyrrolidine 2.5 0.19 0.5 4 100
2-Mercaptoethyl - 2-methoxyethyl-
amine 2.5 0.19 1.0 10 90
N-(2-mercaptoethyl)-acetamide 1.6 0.14 35 11 2.5 0.21 2.5 5 0
2-Mercaptoethyl urea 1.63 0.14 11 27 2.5 0.24 2.5 5 0
N-(2-mercaptoethyl) morpholine 2.0 0.14 7 43 2.5 0.17 0.5 4 0
N-(2-mercaptoethyl)-2-methyl mor-
pholinium iodide 4.9 0.17 4.9 9 0
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TABLE I—Continued
Mercaptan
Man Guinea Pig
.
Sensitizing
concentration
No. of
subjects
Sensi-
tized
.
Sensitizing
concentration
Ch I..a No. of
animals
Sensi-
tized
% Molar % % Molar % %
N-(2-mercaptoethyl) -N-methyl pyr-
rolidinium iodide 5.2 0.17 1.0 9 22
N-(2-mercaptoethyl) pyrrolidone
Miscellaneous Types
1-Mercapto-2, 3-propanediol (Thio-
glycerol)
4-Mercaptomethylbenzoic acid
2-Mercaptoethyl methyl sulfone
2-Mercaptoethane sulfonic acid
3-Mercaptopropane sulfonic acid
4-Mercaptobutane sulfonic acid
1-Dodecanethiol
1.94
1.23
1.47
3.1
0.14
0.11
0.10
0.28
10
52
15
33
90
10—12
53
79
3.1
2.5
2.5
2.5
2.5
2.8
3.1
2.5
0.22
0.23
0.16
0.18
0.23
0.23
0.23
0.12
0.78
2.5
1.0
1.0
2.5
2.8
3.1
0.2
5
10
5
5
10
5
5
10
60
0
60
40
50
80
40
10
Mercaptosuccinic acid
Mercaptosuccinimide
Bis-(2-methoxyethyl) mercaptosuc-
cinic acid
2.04 0.14 11 9 •
2.84
5.8
0.22
0.22
2.84
5.8
5
5
100
100
a,co-Dimercaptoethyl polyethylene
oxide 8.8 0.28 1.8 5 20
Cysteine
3-Amino-4-mercaptobenzoic acid
1.7
2.4
0.14
0.14
64
12
3
4—67 3.7 0.22 0.92 8 0
TABLE II
Relation of Results of ,SensiTtization Tests in Man
and Guinea Pig; Numbers of Mercaptans
Giving the Indicated Results
.Sensi- NotSensi-
tiring
in Man
Not
Tested
in Man
Sensitizing in Guinea Pig....
Not Sensitizing in Guinea Pig
Not Tested in Guinea Pig...
8
11
3
0
2*
0
18
2
—
* One questionable reaction to 3-mercapto-
propionic acid in one animal.
practically the whole surface of the body. There-
fore, sensitization in these tests was characterized
by (a) a frequent appearance of significant reac-
tions (grade 3 or above) early in the third week of
the test, (b) strong reactions on the original
sites at the time of challenge, and (c) strong
reactions on the adjacent sites as well at chal-
lenge. Most of the dilute aqueous solutions used
in this work caused too little primary irritation to
confuse the interpretation of reactions.
RESULTS
The data in Table 1 show the results of human
and animal tests on forty-four mercaptans. Only
two, thioglycolic (mercaptoacetic) acid and
probably 3-mercaptopropionic acid, appeared to
be devoid of significant allergenic activity. Of
the compounds tested, the derivatives of thio-
glycolamide (mercaptoacetamide) were generally
the most strongly allergenic. However, detailed
comparisons of allergenicity, based on these data,
are considered fruitless; in most cases, the num-
bers of animal or human subjects are not
sufficiently large to permit valid comparisons. In
a few instances in which tests were repeated the
incidence of sensitization varied within rather
wide limits, although conclusions as to the pres-
ence or absence of allergenic activity remained
unchanged.
A comparison of the human and guinea pig
tests is summarized in Table II. Forty of the
forty-four compounds tested induced sensitiza-
tion in man and/or guinea pig. Of these forty,
eight induced sensitization in both species, while
eleven sensitized man but failed to sensitize the
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guinea pig. The guinea pig test, therefore, had
useful predictive value in this work, in contrast
to the findings of Smyth and Carpenter (16). It
is noteworthy that the guinea pig gave some false
negative results; it failed to yield any false posi-
tives, although eighteen compounds which sensi-
tized guinea pigs were not tested in man. Thus,
man again appears to be outstandingly suscep-
tible to delayed contact-type sensitization by
simple compounds.
Further studies of sensitization of guinea pigs
showed that five intradermal injections of mer-
captan in Freund's adjuvant (17), as suggested
by Chase (18), followed by five injections of
mercaptan alone, greatly increased the sensi-
tizing potential of the test compound. By this
procedure, it was even possible to sensitize guinea
pigs to thioglycolate. For screening purposes this
method was unsatisfactory, however, because of
its excessive efficiency; much previous experience
and the successful marketing for years of hair-
waving lotions based on thioglycolate have shown
this compound to be essentially non-allergenic
in man. Use of Freund's adjuvant merely revealed
a minimal allergenic activity, which shows the
compound to be quantitatively but not qualita-
tively different from other mercaptans in this
respect. Obviously, a sufficiently weak allergen
may be used by man without a significant occur-
rence of reactions due to sensitization.
DISCUSSION
The data reported here show that some simple
mercaptans belong to a class of water-soluble
allergens, and are capable of inducing a typical,
delayed, contact-type sensitization in man and
guinea pig. it is assumed that these compounds
induce sensitization by splitting disulfide bonds
of skin proteins and forming derived proteins
which serve as the actual allergens (19, 20, 21). A
reaction such as PSSP + RSH — PSSR + P811,
in which P represents protein and RSII the mer-
captan, may be visualized as the mechanism
whereby a haptenic substituent is introduced into
the protein molecule. Separate experiments in
our laboratories, using S35-tagged mercaptans,
have shown this reaction to occur with hair
keratin.
Allergenic activity was found in some degree
with almost all the forty-four mercaptans tested.
Even thioglycolate, which has been widely used
in cosmetic products by miffions of women with
perfect safety, showed a minimal allergenic po-
tential when tested with Freund's adjuvant in
guinea pigs. Since the sulfhydryl group is the
common denominator of these compounds, it
must be assumed that it is the feature responsible
for sensitization, probably by a mechanism such
as that cited above. Allergenic activity of the
sulfhydryl group, of course, may be profoundly
modified by the remainder of the molecule.
Our experience with these compounds has
paralleled that of Draize et al. (8, 13), in that
guinea pig sensitization has been valuable in
predicting sensitization in man. Success in
sensitizing animals, in our hands, depended
chiefly on use of (a) the highest practical concen-
tration of mercaptan to induce sensitization, and
(b) the highest challenging concentration which
failed to produce so much primary irritation as to
obscure specific reactions to the challenge injec-
tion. In addition, the use of topical applications of
2—5% solutions of mercaptans in a mixture of
water, methyl cellosolve, and Tween 80 in the
later work was frequently helpful in defining the
occurrence of hypersensitivity; reactions to
topical challenge appeared to be significantly
more sensitive than were reactions to intradermal
injection.
Sensitization of human subjects was readily
accomplished with all but two of these mercap-
tans, using the "repeated insult" patch test. With
a potent allergen, reactions frequently occurred
at the sixth or seventh application, and progres-
sively greater numbers of subjects showed cvi-
dense of sensitization at the remaining two or
three applications and at the time of challenge.
Unequivocal demonstration that specific hyper-
sensitivity had been induced was generally possi-
ble by (a) production of a new reaction to a non-
irritating concentration of mercaptan applied to
a fresh site; (b) a flare of reaction at the original
site, when a new site was tested; and (c) produc-
tion of reactions at the time of challenge on both
original and new sites, to demonstrate that the
reactivity of the original site was not due to
primary irritation or skin fatigue. In our experi-
ence, the use of the double challenge has proved
extremely useful in interpreting the significance
of the reactions.
Evidence of cross-sensitization to thioglycolate
by other mercaptans was observed in three in-
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stances. This experience emphasizes that not
more than one test compound of this type should
be applied to the same subject. In addition, the
possible uses of the compounds should be con-
sidered; cross-sensitization of female subjects to
thioglycolamide caused reactivity to hair-waving
lotions based on thioglycolate.
The lack of false-positive results in the guinea
pig test, when compared with results of the patch
test, shows that the animal experiments were of
considerable value in this work. No instance was
found in which a compound was allergenic in the
guinea pig and not in man. Therefore, in the
later phases of the work, compounds showing
allergenic activity in the guinea pig were not
tested further in man. The results of this com-
parison are in disagreement with those of Smyth
and Carpenter (16), who reported that false-
positive results with other types of compounds
were frequently obtained in their guinea pig
tests. In our experience, the principal failing of
this test was its inability to detect all of the
mercaptans which were allergenic in man. Conse-
quently, some human subjects were sensitized to
compounds which need not have been evaluated
in patch tests, had the guinea pig been as readily
sensitized as is man. Nevertheless, the need for
patch tests was obviated by use of the guinea pig
method in a number of instances.
Of some interest is the fact that two human
subjects became sensitized to the naturally oc-
curring amino acid, cysteine (or, conceivably, to
some impurity in the sample). The reactivity of
these subjects was studied by further challenge
patch tests, and was found to be persistent and
not due to a non-specific reactivity of the skin.
SUMMARY
Methods of inducing delayed, contact-type
hypersensitivity to mercaptans in man and
guinea pig are described. These methods possess
certain advantages over those customarily em-
ployed. By use of these procedures, a number of
mercaptans of low molecular weight have been
shown to belong to a class of water-soluble
allergens. Of forty-four compounds tested, forty
were found to sensitize man and/or guinea pig.
The guinea pig test for sensitization was found
to be of value in predicting allergenic activity in
man. It gave no false-positive results, but some
false negatives. It is apparent that the guinea
pig is less readily sensitized than is man.
With mercaptans, sensitizing potential in man
was readily revealed by means of the "repeated
insult" patch test. The use of a double patch at
the time of challenge, applied to the original
site and to an adjacent area of previously un-
treated skin, was of much assistance in permitting
one to distinguish hypersensitivity from skin
fatigue persisting at the site of previous applica-
tions of test patches.
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